ImmunityBio, Inc. — Director's Dealing 2022

Feb 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ImmunityBio, Inc. (IBRX)
CIK: 0001326110
Period of Report: 2022-02-05

Reporting Person: Adcock Richard (Director, CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-05	Common Stock	M	83333	—	Acquired	169509	Direct
2022-02-05	Common Stock	F	29415	$5.39	Disposed	140094	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-05	Restricted Stock Units	$	M	83333	Disposed		Common Stock (83333.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1930	Indirect

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.

F2: On February 5, 2022, the Reporting Person's RSUs vested. The RSUs were settled on February 7, 2022, the first business day following the vesting date. The closing price of Immunity Bio, Inc.'s common stock on February 4, 2022 was the settlement price used to calculate the shares withheld.

F3: Shares held by girlfriend living in the same household as the Reporting Person. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F4: Subject to the Reporting Person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 83,333 of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 83,334 of the shares shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 5, 2021.